模拟脂磷壁酸的肽疫苗对小鼠金黄色葡萄球菌感染的保护作用
本研究筛选12肽噬菌体库获得模拟金黄色葡萄球菌脂磷壁酸(LTA)表位的肽序列,合成四分支多抗原肽MAP2-3(含序列GHKEDRQWCQHS)。小鼠免疫MAP2-3可诱导LTA特异性IgG、延长感染后生存时间并降低器官细菌负荷;被动免疫抗MAP2-3血清亦减少菌血症小鼠器官载菌、减轻肺炎急性肺损伤及皮肤感染病灶大小。
要点
- MAP2-3肽可模拟LTA表位并诱导LTA特异性IgG抗体
- 主动免疫延长金葡菌感染小鼠生存时间并降低器官细菌负荷
- 被动免疫抗MAP2-3血清对菌血症、肺炎和皮肤感染小鼠有保护作用
核心结论
- MAP2-3作为LTA的替代物,免疫后可激发体液免疫反应并保护小鼠抵抗金黄色葡萄球菌感染。
- 本研究为设计抗金黄色葡萄球菌疫苗提供了新选择。
研究设计与样本
- 研究筛选12肽噬菌体库,识别可模拟LTA表位的肽序列。
- 合成含阳性序列GHKEDRQWCQHS的四分支多抗原肽MAP2-3,并在小鼠中评估主动与被动免疫保护效果。
主要发现
- MAP2-3免疫诱导LTA特异性IgG抗体,延长金葡菌感染小鼠生存时间并降低器官细菌负荷。
- 被动免疫多克隆抗MAP2-3血清降低菌血症小鼠器官细菌载量、缓解肺炎小鼠急性肺损伤、减小皮肤感染小鼠病灶大小。
- MAP2-3免疫小鼠脾脏LTA特异性抗体分泌细胞数显著高于对照小鼠。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Lipoteichoic acid (LTA), a major component of the cell wall of Staphylococcus aureus (S. aureus), is not generally considered as an ideal vaccine candidate since it is a thymus-independent antigen. In this study, we screened a 12-mer phage peptide library and identified a series of peptide sequences that can mimic the epitope of LTA. A tetra-branched multiple antigenic peptide, named MAP2-3, comprising one of the positive peptide sequences (GHKEDRQWCQHS), was synthesized. Immunization with MAP2-3 induced LTA-specific IgG antibodies, prolonged the survival time, and decreased the bacterial burden in organs of mice infected with S. aureus. Moreover, passive immunization with polyclonal anti-MAP2-3 sera reduced bacterial load in organs of mice with bacteremia, alleviated acute lung injury in mice with pneumonia, and decreased the size of lesions in mice with skin infection. The number of LTA-specific antibody-secreting cells in the spleen of MAP2-3 immunized mice were significantly higher than that in the control mice. In summary, as a surrogate of LTA, vaccination with MAP2-3 elicited humoral immune response and protected mice from S. aureus infection. This study provides a new option to design vaccines against S. aureus.
引用
- Yi XY, Huang ZX, Hou XR, et al. Immunization with a peptide mimicking Lipoteichoic acid protects mice against Staphylococcus aureus infection. Vaccine. 2019. PMID: 31230882. doi:10.1016/j.vaccine.2019.06.024
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。